Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Uterine Hemorrhage × Gynecologic × Clear all

Phase

Status

Completed 15 Unknown 4 Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 327 Uterine Cervical Neoplasms 121 Carcinoma, Ovarian Epithelial 97 Fallopian Tube Neoplasms 93 Endometrial Neoplasms 86 Breast Neoplasms 71 Carcinoma, Non-Small-Cell Lung 63 Neoplasms 45 Melanoma 40 Stomach Neoplasms 39 Colorectal Neoplasms 39 Neoplasm Metastasis 34 Carcinoma, Renal Cell 32 Recurrence 29 Pancreatic Neoplasms 29 Triple Negative Breast Neoplasms 26 Squamous Cell Carcinoma of Head and Neck 26 Uterine Neoplasms 23 Sarcoma 23 Lung Neoplasms 23 Urinary Bladder Neoplasms 22 Peritoneal Neoplasms 21 Colonic Neoplasms 21 Uterine Cervical Dysplasia 20 Esophageal Neoplasms 20 Prostatic Neoplasms 19 Head and Neck Neoplasms 18 Testicular Neoplasms 16 Carcinoma, Transitional Cell 16 Small Cell Lung Carcinoma 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06106633 2025-04-24

PEDD-UFE

Massachusetts General Hospital

Phase NA Terminated

Leiomyoma, Uterine Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡